Literature DB >> 30339108

Anxiety as a risk factor of Alzheimer's disease and vascular dementia.

Eva Becker1, Claudia Lorena Orellana Rios2, Claas Lahmann3, Gerta Rücker4, Joachim Bauer5, Martin Boeker6.   

Abstract

BACKGROUND: The aetiology of dementia is not yet fully understood. Stress can have a damaging effect on brain health. The prognostic effect of anxiety is still unclear regarding Alzheimer's disease as well as vascular dementia.AimsTo explore the association between anxiety and future dementia.
METHOD: Medline, PsycINFO, CINAHL, Web of Science and ALOIS were searched for publications up to 12 January 2018. Longitudinal studies with a follow-up of at least 2 years were included, if the trait or state anxiety had been assessed at baseline. Studies with cognitive impairment at baseline were not included. We used a random effects model to calculate the pooled time to Alzheimer's disease and incidence of vascular dementia.
RESULTS: Anxiety predicts risk of Alzheimer's disease (n = 26 193 out of seven studies, hazard ratio1.53, 95% CI 1.16-2.01, P < 0.01) and vascular dementia (n = 4916 out of two studies, odds ratio1.88, 95% CI 1.05-3.36, P < 0.01). The pooled hazard ratio regarding risk of Alzheimer's disease was still significant when excluding studies with critical risk of bias (n = 14 110 out of six studies, hazard ratio 1.35, 95% CI 1.08-1.70, P < 0.01).
CONCLUSIONS: Anxiety is a risk factor for both types of dementia. The temporal and functional relation between anxiety and dementia needs investigation in future studies. The protective value of treating anxiety should be explored further.Declaration of interestNone.

Entities:  

Keywords:  Anxiety disorders; aetiology; dementia

Mesh:

Year:  2018        PMID: 30339108     DOI: 10.1192/bjp.2018.173

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  27 in total

1.  Psychological distress links perceived neighborhood characteristics to longitudinal trajectories of cognitive health in older adulthood.

Authors:  Neika Sharifian; Briana N Spivey; Afsara B Zaheed; Laura B Zahodne
Journal:  Soc Sci Med       Date:  2020-06-19       Impact factor: 4.634

Review 2.  Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia.

Authors:  Ramon Cacabelos
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 3.  [Rheumatism and the mind-A mini review].

Authors:  D Linsmayer; P-K Neidlinger; D F Braus
Journal:  Orthopade       Date:  2019-11       Impact factor: 1.087

4.  Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.

Authors:  Michael A Kelberman; Claire R Anderson; Eli Chlan; Jacki M Rorabaugh; Katharine E McCann; David Weinshenker
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

5.  Elevated Risk of Cognitive Impairment Among Older Sexual Minorities: Do Health Conditions, Health Behaviors, and Social Connections Matter?

Authors:  Ning Hsieh; Hui Liu; Wen-Hua Lai
Journal:  Gerontologist       Date:  2021-04-03

6.  Purpose in life is a robust protective factor of reported cognitive decline among late middle-aged adults: The Emory Healthy Aging Study.

Authors:  Aliza P Wingo; Thomas S Wingo; Wen Fan; Sharon Bergquist; Alvaro Alonso; Michele Marcus; Allan I Levey; James J Lah
Journal:  J Affect Disord       Date:  2019-11-30       Impact factor: 4.839

Review 7.  Harnessing the effects of endurance exercise to optimize cognitive health: Fundamental insights from Dr. Mark P. Mattson.

Authors:  Sarah K Jachim; Ayumi E Sakamoto; Xu Zhang; Vesselina M Pearsall; Marissa J Schafer; Nathan K LeBrasseur
Journal:  Ageing Res Rev       Date:  2020-08-16       Impact factor: 10.895

8.  Cerebroprotein Hydrolysate-I Inhibits Hippocampal Neuronal Apoptosis by Activating PI3K/Akt Signaling Pathway in Vascular Dementia Mice.

Authors:  Xiaolin Wu; Yingjuan Liu; Lin Zhu; Yue Wang; Yuqian Ren; Baohe Cheng; Leiming Ren; Keli Ge; Hongyun Li
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-17       Impact factor: 2.570

Review 9.  Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer's Disease.

Authors:  Angeles Vinuesa; Carlos Pomilio; Amal Gregosa; Melisa Bentivegna; Jessica Presa; Melina Bellotto; Flavia Saravia; Juan Beauquis
Journal:  Front Neurosci       Date:  2021-04-23       Impact factor: 4.677

Review 10.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.